Cargando…
Mechanistic insights into the inhibition of NTCP by myrcludex B
BACKGROUND & AIMS: The sodium taurocholate co-transporting polypeptide (NTCP) is the entry receptor for the hepatitis B and delta virus (HBV/HDV) and the main hepatic uptake transporter of conjugated bile acids. Myrcludex B, a synthetic peptide mimicking the NTCP-binding domain of HBV, blocks HB...
Autores principales: | Donkers, Joanne M., Appelman, Monique D., van de Graaf, Stan F.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001544/ https://www.ncbi.nlm.nih.gov/pubmed/32039379 http://dx.doi.org/10.1016/j.jhepr.2019.07.006 |
Ejemplares similares
-
Inhibition of Hepatic Bile Acid Uptake by Myrcludex B Promotes Glucagon-Like Peptide-1 Release and Reduces Obesity
por: Donkers, Joanne M., et al.
Publicado: (2020) -
N-Glycosylation of the Na+-Taurocholate Cotransporting Polypeptide (NTCP) Determines Its Trafficking and Stability and Is Required for Hepatitis B Virus Infection
por: Appelman, Monique D., et al.
Publicado: (2017) -
NTCP deficiency in mice protects against obesity and hepatosteatosis
por: Donkers, Joanne M., et al.
Publicado: (2019) -
The Lipid Raft Component Stomatin Interacts with the Na(+) Taurocholate Cotransporting Polypeptide (NTCP) and Modulates Bile Salt Uptake
por: Appelman, Monique D., et al.
Publicado: (2020) -
Insufficient evidence for NTCP activity in stellate cells
por: Kunst, Roni F, et al.
Publicado: (2022)